JOSHUA D LEE
Affiliation: New York University
- Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: rationale and design of a randomized controlled effectiveness trialJOSHUA D LEE
Department of Population Health and Division of General Internal Medicine, New York University, United States Electronic address
Contemp Clin Trials 41:110-7. 2015..is an injectable monthly sustained-release mu opioid receptor antagonist. XR-NTX is a potentially effective intervention for opioid use disorders and as relapse prevention among criminal justice system (CJS) populations...
- Extended-release naltrexone plus medical management alcohol treatment in primary care: findings at 15 monthsJOSHUA D LEE
New York University School of Medicine, NY, USA
J Subst Abuse Treat 43:458-62. 2012..38% days abstinent; 11 vs. 61% heavy drinking days. Long-term XR-NTX treatment in a primary care MM model was feasible and may promote lasting drinking reductions or alcohol abstinence (clinical trial: NCT00620750)...
- Buprenorphine-naloxone maintenance following release from jailJOSHUA D LEE
Division of General Internal Medicine, New York University School of Medicine, New York, New York, USA
Subst Abus 33:40-7. 2012..Postrelease patients in primary care buprenorphine treatment had equal treatment retention and rates of opioid abstinence versus community-referred patients...
- Working with patients with alcohol problems: a controlled trial of the impact of a rich media web module on medical student performanceJOSHUA D LEE
Division of General Internal Medicine, New York University School of Medicine, New York, NY, USA
J Gen Intern Med 23:1006-9. 2008..We designed an interactive web module to improve medical student competence in screening and interventions for hazardous drinking. We assessed its impact on performance with a standardized patient (SP) vs. traditional lecture...
- Substance use prevalence and screening instrument comparisons in urban primary careJOSHUA D LEE
Division of General Internal Medicine, New York University School of Medicine, New York, New York 10010, USA
Subst Abus 32:128-34. 2011..The NIAAA single item correlated closely with alcohol ASSIST. TICS and EMR were less sensitive for any nontobacco substance use...
- Extended-release naltrexone for treatment of alcohol dependence in primary careJOSHUA D LEE
New York University School of Medicine, New York, NY 10010, USA
J Subst Abuse Treat 39:14-21. 2010..1 (95% confidence interval = 2.9-6) at baseline to 0.5 (0-1.7) during Month 3. Extended-release naltrexone delivered in a primary care MM model appears a feasible and acceptable treatment for alcohol dependence...
- Home buprenorphine/naloxone induction in primary careJOSHUA D LEE
New York University School of Medicine, New York, NY, USA
J Gen Intern Med 24:226-32. 2009..We offered buprenorphine treatment at a public hospital primary care clinic using a home, unobserved induction protocol...
- Teaching physicians to address unhealthy alcohol use: a randomized controlled trial assessing the effect of a Web-based module on medical student performanceAndrea Truncali
Department of Medicine, New York University School of Medicine, New York, NY 10016, USA
J Subst Abuse Treat 40:203-13. 2011..The authors developed and evaluated an interactive, Web-based module to train medical students in screening and brief intervention (SBI) for unhealthy alcohol use...
- Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trialJOSHUA D LEE
Department of Population Health, New York University School of Medicine, New York, NY, USA
Addiction 110:1008-14. 2015..Relapse to addiction following incarceration is common. We estimated the feasibility and effectiveness of extended-release naltrexone (XR-NTX) as relapse prevention among opioid-dependent male adults leaving a large urban jail...
- Psychiatric comorbidity, red flag behaviors, and associated outcomes among office-based buprenorphine patients following Hurricane SandyArthur R Williams
New York University, New York City, NY, USA
J Urban Health 91:366-75. 2014..Additionally, patients endorsing new-onset psychiatric manifestations following disasters may be an especially high-risk group for poor outcomes, warranting further study. ..
- Mobile Phone Messaging During Unobserved "Home" Induction to BuprenorphineBabak Tofighi
Department of Population Health, New York University School of Medicine BT, SS, JDL Department of Medicine, Division of General Internal Medicine, New York University School of Medicine BT, Eg, SS, JDL Department of Psychiatry, New York University School of Medicine SS New York State Psychiatric Institute, EVN and Columbia University Department of Psychiatry, EVN, New York, NY
J Addict Med 10:309-13. 2016..The case highlights the use of text message-based physician-patient communication to facilitate unobserved "home" induction onto buprenorphine. ..
- Psychiatric Comorbidity and Substance Use Outcomes in an Office-Based Buprenorphine Program Six Months Following Hurricane SandyBabak Tofighi
a Department of Population Health, New York University School of Medicine, New York, New York, USA
Subst Use Misuse 50:1571-8. 2015..On October 2012, Hurricane Sandy struck New York City, resulting in unprecedented damages, including the temporary closure of Bellevue Hospital Center and its primary care office-based buprenorphine program...
- Mobile phone use patterns and preferences in safety net office-based buprenorphine patientsBabak Tofighi
From the Department of Population Health BT, EB, JM, MG, JDL, and Division of General Internal Medicine BT, Eg, EB, JM, MG, JDL, New York University School of Medicine, New York, New York
J Addict Med 9:217-21. 2015..Few studies have evaluated mobile phone and text message (TM) use patterns in persons enrolled in addiction treatment, and none have assessed the use in safety net, office-based buprenorphine practices...
- Outcomes among buprenorphine-naloxone primary care patients after Hurricane SandyBabak Tofighi
Department of Population Health, New York University School of Medicine, 227 E, 30th St, 7th Floor, New York, NY 10016, USA
Addict Sci Clin Pract 9:3. 2014....
- Test-retest reliability of a self-administered Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in primary care patientsJennifer McNeely
Department of Population Health and Department of Medicine, Division of General Internal Medicine, New York University School of Medicine, 550 1st Avenue, VZ30, 6th Floor, New York, NY 10016 Electronic address
J Subst Abuse Treat 47:93-101. 2014..90-0.97) for tobacco, alcohol, and drugs. The ACASI ASSIST has good test-retest reliability, and warrants additional study to evaluate its validity for detecting unhealthy substance use...
- Undergraduate medical education in substance abuse: a review of the quality of the literatureDevyani Kothari
Substance Abuse Research and Education Training SARET Program, New York University School of Medicine, New York, New York, USA
Acad Med 86:98-112. 2011..To prepare to develop a medical school curriculum on substance abuse disorders (SADs), the authors conducted a review of the quality of the sparse published literature...
- NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationaleJOSHUA D LEE
New York University School of Medicine, New York, NY, United States Electronic address
Contemp Clin Trials 50:253-64. 2016..This study is intended to develop an evidence-base to help patients and providers make informed choices and to foster wider adoption of relapse-prevention pharmacotherapies...
- Internet highs--seizures after consumption of synthetic cannabinoids purchased onlineBabak Tofighi
Lenox Hill Hospital, 100 East 77th Street, New York, NY 10075, USA
J Addict Med 6:240-1. 2012..In addition, after reports in lay media of seizures and coma attributed to the consumption of the drug, anecdotal reports have emerged of similar findings in the medical literature...
- Rate of community methadone treatment reporting at jail reentry following a methadone increased dose quality improvement effortAndiea Harris
Prison Health Services, Inc, New York, New York, USA
Subst Abus 33:70-5. 2012..Patients who reached a moderate-to-high methadone dose demonstrated higher rates of reporting to community MTP versus lower doses, both pre- and post-QI. Overall, a higher proportion of all patients reported to community MTP post-QI...